Comparative Molecular Field Analysis(CoMFA) of Curcumin-related Compounds for Anticancer Activity

被引:4
|
作者
周代营 [1 ,2 ,3 ]
杜志云 [1 ]
汤志恺 [4 ]
郑希 [1 ,3 ]
丁宁 [3 ]
郑俊霞 [1 ]
王辉 [1 ]
张焜 [1 ]
机构
[1] Allan H Conney Laboratory for Anticancer Research, Institute of Natural Medicinal Chemistry & Green Chemistry, Guangdong University of Technology
[2] Guangdong Food and Drug Vocational College
[3] Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey
[4] Guangzhou Improve Medical Technology Co,
关键词
D O I
暂无
中图分类号
TQ460.1 [基础理论];
学科分类号
摘要
Three-dimensional(3D) quantitative structure-activity relationship(QSAR) studies of 44 curcumin-related compounds have been carried out based on our previously reported result for their anticancer activity against pancreas cancer Panc-1 cells and colon cancer HT-29 cells. The established 3D-QSAR models from the comparative molecular field analysis(CoMFA) in training set showed not only significant statistical quality, but also satisfying predictive ability, with high correlation coefficient values(R1 2 = 0.911, R2 2 = 0.985) and cross-validation coefficient values(q1 2 = 0.580, q2 2 = 0.722). Based on the CoMFA contour maps, some key structural factors responsible for anticancer activity of these series of compounds were revealed. The results provide some useful theoretical references for understanding the mechanism of action, designing new curcumin-related compounds with anticancer activity and predicting their activities prior to synthesis.
引用
收藏
页码:179 / 188
页数:10
相关论文
共 50 条
  • [31] ANTIOXIDANT ACTIVITY OF CURCUMIN AND RELATED COMPOUNDS
    SHARMA, OP
    BIOCHEMICAL PHARMACOLOGY, 1976, 25 (15) : 1811 - 1812
  • [32] Selectivity fields: Comparative molecular field analysis (CoMFA) of the glycine/NMDA and AMPA receptors
    Baskin, II
    Tikhonova, IG
    Palyulin, VA
    Zefirov, NS
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (19) : 4063 - 4069
  • [33] Synthesis and comparative molecular field analysis (CoMFA) of antitumor 3-arylisoquinoline derivatives
    Cho, WJ
    Kim, EK
    Park, MJ
    Choi, SU
    Lee, CO
    Cheon, SH
    Choi, BG
    Chung, BH
    BIOORGANIC & MEDICINAL CHEMISTRY, 1998, 6 (12) : 2449 - 2458
  • [34] APPLICATION OF COMPARATIVE MOLECULAR-FIELD ANALYSIS (COMFA) TO INHIBITORS OF PHOTOSYSTEM-II
    PATTERSON, D
    CRAMER, R
    HECHT, P
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 29 - AGRO
  • [35] Evaluation of hydrophobic/hydrophilic balance of bile acids by comparative molecular field analysis (CoMFA)
    Costantino, G
    Wolf, C
    Natalini, B
    Pellicciari, R
    STEROIDS, 2000, 65 (09) : 483 - 489
  • [36] STRUCTURE-BASED COMPARATIVE MOLECULAR-FIELD ANALYSIS (COMFA) OF ACETYLCHOLINESTERASE INHIBITORS
    SERRANO, ML
    CHO, SJ
    BIER, J
    TROPSHA, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 187 - COMP
  • [37] Comparative molecular field analysis (CoMFA) on [6]+[6] fused pyrazines with nematocide properties
    Martínez, A
    Ochoa, C
    Rodríguez, J
    Rodríguez, M
    Castro, A
    González, M
    Martínez, MM
    QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS, 1997, 16 (05): : 372 - 376
  • [38] Curcumin: An Insight into Molecular Pathways Involved in Anticancer Activity
    Joshi, Priyanka
    Joshi, Sushil
    Semwal, Deepak
    Bisht, Akansha
    Paliwal, Sarvesh
    Dwivedi, Jaya
    Sharma, Swapnil
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2021, 21 (17) : 2434 - 2471
  • [39] Synthesis and Evaluation of Curcumin-Related Compounds Containing Inden-2-one for Their Effects on Human Cancer Cells
    Zhou, Daiying
    Ding, Ning
    Zhao, Suqing
    Li, Dongli
    Van Doren, Jeremiah
    Qian, Yu
    Wei, Xingchuan
    Zheng, Xi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2014, 37 (12) : 1977 - 1981
  • [40] Elucidation of anti-allergic activities of curcumin-related compounds with a special reference to their anti-oxidative activities
    Suzuki, M
    Nakamura, T
    Iyoki, S
    Fujiwara, A
    Watanabe, Y
    Mohri, K
    Isobe, K
    Ono, K
    Yano, S
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (08) : 1438 - 1443